Login
Who's Online
We have 1045 guests and no members online
Statistics
- Users 5524
- Articles 739
- Articles View Hits 17227089
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- CRISPR-based gene therapy shows promise for muscular dystrophy - RegMedNet
Fri, 17 Jan 2025 15:26:1 GMT - Sangamo Nearing Fabry Gene Therapy Deal To Fund Its Pipeline - insights.citeline.com
Fri, 17 Jan 2025 01:53:5 GMT - HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws' - Benzinga
Thu, 16 Jan 2025 20:10:3 GMT - Phase 2 trial of AskBio’s gene therapy assigns its first participants - Parkinson's News Today
Thu, 16 Jan 2025 17:59:2 GMT - Viral Vectors-Based Gene Therapy for Non-Human Primates to - GlobeNewswire
Thu, 16 Jan 2025 17:01:1 GMT - Gene Therapy in Hemophilia: High Hopes and Costs, Low Uptake - Medscape
Thu, 16 Jan 2025 10:08:0 GMT - Umoja raises $100 million to boost its CAR-T cell gene therapy pipeline - BioPharma-Reporter.com
Thu, 16 Jan 2025 08:56:1 GMT - Solid Biosciences Advances Gene Therapy Pipeline, Reports Strong $148.9M Cash Position - StockTitan
Wed, 15 Jan 2025 22:05:0 GMT - Fatal neurodegenerative disease in kids also affects the bowel—gene therapy may help - Medical Xpress
Wed, 15 Jan 2025 21:49:0 GMT - Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models - Science
Wed, 15 Jan 2025 20:13:2 GMT - Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy - Genetic Engineering & Biotechnology News
Wed, 15 Jan 2025 18:17:3 GMT - Spark Therapeutics co-founder back at the helm of a Philadelphia gene therapy company - The Business Journals
Tue, 14 Jan 2025 21:00:0 GMT - Fresh off AbbVie update, Regenxbio inks $810M MPS gene therapy deal - FirstWord Pharma
Tue, 14 Jan 2025 16:22:1 GMT - RhyGaze raises $86 million to develop vision restoration gene therapy - Healio
Tue, 14 Jan 2025 15:42:2 GMT - FDA gives go-ahead for clinical testing of FA gene therapy SGT-212 - Friedreich's Ataxia News
Tue, 14 Jan 2025 14:51:2 GMT